Author:
Kruger P,Cooney J,Nivison-Smith I,Dodds A,Bardy P,Ma D,Szer J,Durrant S
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference15 articles.
1. Saussele S, Lauseker M, Müller MC, Gratwohl A, Beelen D, Bunjes DW et al2567 Allogeneic hematopoietic stem cell transplantation (HSCT) in the imatinib-era: update on the survival outcome following allogeneic HSCT after imatinib failure; results of the German CML Study IV. 56th ASH Annual Meeting and Exposition; 6–9 December 2014; San Francisco, CA, USA.
2. Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355: 2408–2417.
3. Barrett AJ, Ito S . The role of stem cell transplantation for chronic myelogenous leukaemia in the 21st century. Blood 2015; 125: 3230–3235.
4. Jabbour E, Cortes J, Kantarjian HM, Giralt S, Jones D, Jones R et al. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia and acute lymphocytic leukemia after Bcr-Abl kinase mutation-related imatinib failure. Blood 2006; 108: 1421–1423.
5. Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Ma DD, Moore JJ et al. Hematopoietic stem cell transplantation in Australia and New Zealand, 1992-2004. Biol Blood Marrow Transplant 2007; 13: 905–912.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献